ACE2 and COVID-19: After COVID-19 invaded the human body, it bound to the angiotensin-converting enzyme 2 (ACE2) receptors of β cells, adipocytes and liver cells, directly damaging islet beta cells, fat, and liver cells, further aggravating insulin resistance (57).